# Biologics Supply Chain Dashboard

This dashboard summarizes key findings and visualizations from the biologics supply chain analysis, including sales trends, safety stock, forecast, optimization, and risk metrics.

**Summary of Findings:**
- Sales and safety stock trends are visualized for all products.
- Stockout risk is low for most products, except N05C.
- Inventory optimization models provide recommended stock levels per material and week.
- FDA shortage data highlights top risk biologics.
